Multifunctional rare-earth vanadate nanoparticles: Luminescent labels, oxidant sensors, and MRI contrast agents

ACS Nano

Volumn 8, Issue 11, 2014, Pages 11126-11137

  Abdesselem, Mouna ^a   Schoeffel, Markus ^a   Maurin, Isabelle ^a   Ramodiharilafy, Rivo ^a   Autret, Gwennhael ^b   Clément, Olivier ^b   Tharaux, Pierre Louis ^b   Boilot, Jean Pierre ^a   Gacoin, Thierry ^a   Bouzigues, Cedric ^a   Alexandrou, Antigoni ^a  

^a ECOLE POLYTECHNIQUE   (France)

^b PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

Author keywords

Contrast agent; Lanthanide nanoparticles; MRI; Multifunctional probe; Oxidant sensor

Indexed keywords

EUROPIUM COMPOUNDS; GADOLINIUM COMPOUNDS; LUMINESCENCE; MAGNETIC RESONANCE IMAGING; MAMMALS; NANOMAGNETICS; NANOPARTICLES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDANTS; PROBES; RARE EARTHS; RESONANCE; SYNTHESIS (CHEMICAL); TITRATION;

COMPLEXOMETRIC TITRATION; CONTRAST AGENT; LANTHANIDE NANOPARTICLES; LUMINESCENCE EMISSION; MAGNETIC RESONANCE DISPERSIONS; MULTI-FUNCTIONAL NANOPARTICLES; MULTIFUNCTIONAL PROBES; RARE EARTH VANADATES;

VANADIUM COMPOUNDS;

CONTRAST MEDIUM; LANTHANIDE; NANOPARTICLE; OXIDIZING AGENT; VANADIUM;

ANIMAL; CHEMISTRY; INFRARED SPECTROSCOPY; LUMINESCENCE; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CONTRAST MEDIA; LUMINESCENCE; MAGNETIC RESONANCE IMAGING; METALS, RARE EARTH; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OXIDANTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; VANADIUM;

EID: 84912535996     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn504170x     Document Type: Article

References (67)

1. Malam, Y.; Loizidou, M.; Seifalian, A. M. Liposomes and Nanoparticles: Nanosized Vehicles for Drug Delivery in Cancer. Trends Pharmacol. Sci. 2009, 30, 592-599.
2. Cheng, Z.; Al Zaki, A.; Hui, J. Z.; Muzykantov, V. R.; Tsourkas, A. Multifunctional Nanoparticles: Cost versus Benefit of Adding Targeting and Imaging Capabilities. Science 2012, 338, 903-910.
3. Goldys, E. Fluorescence Applications in Biotechnology and Life Sciences; John Wiley & Sons, Inc.: Hoboken, NJ, 2009.
4. Michalet, X.; Pinaud, F. F.; Bentolila, L. A.; Tsay, J. M.; Doose, S.; Li, J. J.; Sundaresan, G.; Wu, A. M.; Gambhir, S. S.; Weiss, S. Quantum Dots for Live Cells, In Vivo Imaging, and Diagnostics. Science 2005, 307, 538-544.
5. Westbrook, C.; Roth, C.; Talbot, J. MRI in Practice, 4th ed.; Wiley-Blackwell: Oxford, 2011.
6. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Vander Elst, L.; Muller, R. N. Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications. Chem. Rev. 2008, 108, 2064-2110.
7. Wang, Y. X.; Hussain, S. M.; Krestin, G. P. Superparamagnetic Iron Oxide Contrast Agents: Physicochemical Characteristics and Applications in MR Imaging. Eur. Radiol. 2001, 11, 2319-2331.
8. Geraldes, C. F. G. C.; Laurent, S. Classification and Basic Properties of Contrast Agents for Magnetic Resonance Imaging. Contrast Media Mol. Imaging 2009, 4, 1-23.
9. Caravan, P.; Ellison, J. J.; McMurry, T. J.; Lauffer, R. B. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem. Rev. 1999, 99, 2293-2352.
10. Hüber, M. M.; Staubli, A. B.; Kustedjo, K.; Gray, M. H.; Shih, J.; Fraser, S. E.; Jacobs, R. E.; Meade, T. J. Fluorescently Detectable Magnetic Resonance Imaging Agents. Bioconjugate Chem. 1998, 9, 242-249.
11. Zhang, X.; Jing, X.; Liu, T.; Han, G.; Li, H.; Duan, C. Dual-Functional Gadolinium-Based Copper(II) Probe for Selective Magnetic Resonance Imaging and Fluorescence Sensing. Inorg. Chem. 2012, 51, 2325-2331.
12. Kelly, K. A.; Allport, J. R.; Tsourkas, A.; Shinde-Patil, V. R.; Josephson, L.; Weissleder, R. Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle. Circ. Res. 2005, 96, 327-336.
13. Mulder, W. J. M.; Koole, R.; Brandwijk, R. J.; Storm, G.; Chin, P. T. K.; Strijkers, G. J.; de Mello Donegá, C.; Nicolay, K.; Griffioen, A. W. Quantum Dots with a Paramagnetic Coating as a Bimodal Molecular Imaging Probe. Nano Lett. 2006, 6, 1-6.
14. Bridot, J.-L.; Dayde, D.; Rivière, C.; Mandon, C.; Billotey, C.; Lerondel, S.; Sabattier, R.; Cartron, G.; Le Pape, A.; Blondiaux, G.; et al. Hybrid Gadolinium Oxide Nanoparticles Combining Imaging and Therapy. J. Mater. Chem. 2009, 19, 2328.
15. 1 Contrast Agent for Stem Cell Labeling. Contrast Media Mol. Imaging 2010, 5, 105-111.
16. 1-Weighted MR and Photoluminescence Imaging. Biomaterials 2012, 33, 5865-5874.
17. Zhou, J.; Sun, Y.; Du, X.; Xiong, L.; Hu, H.; Li, F. Dual-Modality In Vivo Imaging Using Rare-Earth Nanocrystals with Near-Infrared to Near-Infrared (NIR-to-NIR) Upconversion Luminescence and Magnetic Resonance Properties. Biomaterials 2010, 31, 3287-3295.
18. Bouzigues, C.; Gacoin, T.; Alexandrou, A. Biological Applications of Rare-Earth Based Nanoparticles. ACS Nano 2011, 5, 8488-8505.
19. Mialon, G.; Türkcan, S.; Alexandrou, A.; Gacoin, T.; Boilot, J.-P. New Insights into Size Effects in Luminescent Oxide Nanocrystals. J. Phys. Chem. C 2009, 113, 18699-18706.
20. Casanova, D.; Bouzigues, C.; Nguyên, T.-L.; Ramodiharilafy, R. O.; Bouzhir-Sima, L.; Gacoin, T.; Boilot, J.-P.; Tharaux, P.-L.; Alexandrou, A. Single Europium-Doped Nanoparticles Measure Temporal Pattern of Reactive Oxygen Species Production inside Cells. Nat. Nanotechnol. 2009, 4, 581-585.
21. D'Autréaux, B.; Toledano, M. B. ROS as Signalling Molecules: Mechanisms That Generate Specificity in ROS Homeostasis. Nat. Rev. Mol. Cell Biol. 2007, 8, 813-824.
22. 2, a Necessary Evil for Cell Signaling. Science 2006, 312, 1882-1883.
23. Clempus, R. E.; Griendling, K. K. Reactive Oxygen Species Signaling in Vascular Smooth Muscle Cells. Cardiovasc. Res. 2006, 71, 216-225.
24. 2 for Platelet-Derived Growth Factor Signal Transduction. Science 1995, 270, 296-299.
25. Hensley, K.; Robinson, K. A.; Gabbita, S. P.; Salsman, S.; Floyd, R. A. Forum on Therapeutic Applications of Reactive Oxygen and Nitrogen Species in Human Disease. Free Radical Biol. Med. 2000, 28, 1449-1450.
26. Wolfbeis, O.; Dürkop, A. A Europium Ion Based Luminescent Sensing Probe for Hydrogen Peroxide. Angew. Chem., Int. Ed. 2002, 1, 4495-4498.
27. Belousov, V. V.; Fradkov, A. F.; Lukyanov, K. A.; Staroverov, D. B.; Shakhbazov, K. S.; Terskikh, A. V.; Lukyanov, S. Genetically Encoded Fluorescent Indicator for Intracellular Hydrogen Peroxide. Nat. Methods 2006, 3, 281-286.
28. Miller, E. W.; Tulyathan, O.; Tulyanthan, O.; Isacoff, E. Y.; Chang, C. J. Molecular Imaging of Hydrogen Peroxide Produced for Cell Signaling. Nat. Chem. Biol. 2007, 3, 263-267.
29. Lee, D.; Khaja, S.; Velasquez-Castano, J. C.; Dasari, M.; Sun, C.; Petros, J.; Taylor, W. R.; Murthy, N. In Vivo Imaging of Hydrogen Peroxide with Chemiluminescent Nanoparticles. Nat. Mater. 2007, 6, 765-769.
30. Bouzigues, C. I.; Nguyên, T.-L.; Ramodiharilafy, R.; Claeson, A.; Tharaux, P.-L.; Alexandrou, A. Regulation of the ROS Response Dynamics and Organization to PDGF Motile Stimuli Revealed by Single Nanoparticle Imaging. Chem. Biol. 2014, 21, 647-656.
31. 3+-Doped Oxide Nanoparticles. Biophys. J. 2012, 102, 2299-2308.
32. Türkcan, S.; Alexandrou, A.; Masson, J.-B. A Bayesian Inference Scheme To Extract Diffusivity and Potential Fields from Confined Single-Molecule Trajectories. Biophys. J. 2012, 102, 2288-2298.
33. Cuzzocrea, S.; Riley, D. P.; Caputi, A. P.; Salvemini, D. Antioxidant Therapy: A New Pharmacological Approach in Shock, Inflammation, and Ischemia/Reperfusion Injury. Pharmacol. Rev. 2001, 53, 135-159.
34. Chinta, S. J.; Andersen, J. K. Redox Imbalance in Parkinson's Disease. Biochim. Biophys. Acta 2008, 1780, 1362-1367.
35. Gupta, S. C.; Hevia, D.; Patchva, S.; Park, B.; Koh, W.; Aggarwal, B. B. Upsides and Downsides of Reactive Oxygen Species for Cancer: The Roles of Reactive Oxygen Species in Tumorigenesis, Prevention, and Therapy. Antioxid. Redox Signal. 2012, 16, 1295-1322.
36. Toyokuni, S.; Okamoto, K.; Yodoi, J.; Hiai, H. Persistent Oxidative Stress in Cancer. FEBS Lett. 1995, 358, 1-3.
37. Ishikawa, K.; Takenaga, K.; Akimoto, M.; Koshikawa, N.; Yamaguchi, A.; Imanishi, H.; Nakada, K.; Honma, Y.; Hayashi, J.-I. ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis. Science 2008, 320, 661-664.
38. Ramsey, M. R.; Sharpless, N. E. ROS as a Tumour Suppressor? Nat. Cell Biol. 2006, 8, 1213-1215.
39. Liu, B.; Chen, Y.; Clair, D. S. ROS and p53: A Versatile Partnership. Free Radical Biol. Med. 2008, 44, 1529-1535.
40. Van de Bittner, G. C.; Bertozzi, C. R.; Chang, C. J. Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation. J. Am. Chem. Soc. 2013, 135, 1783-1795.
41. Van de Bittner, G. C.; Dubikovskaya, E. A.; Bertozzi, C. R.; Chang, C. J. In Vivo Imaging of Hydrogen Peroxide Production in a Murine Tumor Model with a Chemoselective Bioluminescent Reporter. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 21316-21321.
42. 13C MRI Contrast Agent. J. Am. Chem. Soc. 2011, 133, 3776-3779.
43. 4:Eu Phosphors. Chem. Mater. 2000, 12, 1090-1094.
44. 4:Eu Colloids. Chem. Mater. 2002, 14, 2264-2269.
45. 4. Inorg. Mater. 2008, 44, 1121-1124.
46. 4Ln (Ln = Eu, Dy, and Sm) Microstructures: Solvothermal and Luminescent Properties. J. Optoelectron. Adv. Mater. 2011, 5, 596-599.
47. 2 Nanocomposites for Metal-Enhanced Fluorescence and Single Nanoparticle Sensing Platforms. J. Am. Chem. Soc. 2007, 129, 1524-1525.
48. Lauffer, R. B. Paramagnetic Metal Complexes as Water Proton Relaxation Agents for NMR Imaging: Theory and Design. Chem. Rev. 1987, 87, 901-927.
49. Aime, S.; Botta, M.; T, E. Gd(III)-Based Contrast Agents for MRI. Adv. Inorg. Chem. 2005, 57, 173-237.
50. Sengers, J. V.; Watson, J. T. R. Improved International Formulations for the Viscosity and Thermal Conductivity of Water Substance. J. Phys. Chem. Ref. Data 1986, 15, 1291.
51. 3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach 1. J. Am. Chem. Soc. 1996, 118, 9333-9346.
52. Van Vleck, J. The Theory of Electric and Magnetic Susceptibilities; Oxford University Press: Oxford, 1932.
53. Caillé, J. M.; Lemanceau, B.; Bonnemain, B. Gadolinium as a Contrast Agent for NMR. Am. J. Neuroradiol. 1983, 4, 1041-1042.
54. Penfield, J. G.; Reilly, R. F. What Nephrologists Need To Know about Gadolinium. Nat. Clin. Pract. Nephrol. 2007, 3, 654-668.
55. Haley, T. J.; Komesu, N.; Colvin, G.; Koste, L.; Upham, H. C. Pharmacology and Toxicology of Europium Chloride. J. Pharm. Sci. 1965, 54, 643-645.
56. Buissette, V.; Giaume, D.; Gacoin, T.; Boilot, J.-P. Aqueous Routes to Lanthanide-Doped Oxide Nanophosphors. J. Mater. Chem. 2006, 16, 529.
57. Beyersmann, D.; Hartwig, A. Carcinogenic Metal Compounds: Recent Insight into Molecular and Cellular Mechanisms. Arch. Toxicol. 2008, 82, 493-512.
58. Sanchez, D.; Ortega, A.; Domingo, J. L.; Corbella, J. Developmental Toxicity Evaluation of Orthovanadate in the Mouse. Biol. Trace Elem. Res. 1991, 30, 219-226.
59. Hifumi, H.; Yamaoka, S.; Tanimoto, A.; Citterio, D.; Suzuki, K. Gadolinium-Based Hybrid Nanoparticles as a Positive MR Contrast Agent. J. Am. Chem. Soc. 2006, 128, 15090-15091.
60. 3 Particles. Chem. Mater. 2008, 20, 3840-3848.
61. Port, M.; Meyer, D.; Bonnemain, B.; Corot, C.; Schaefer, M.; Rousseaux, O.; Simonot, C.; Bourrinet, P.; Benderbous, S.; Dencausse, A.; et al. P760 and P775: MRI Contrast Agents Characterized by New Pharmacokinetic Properties. MAGMA 1999, 8, 172-176.
62. Na, H. B.; Song, I. C.; Hyeon, T. Inorganic Nanoparticles for MRI Contrast Agents. Adv. Mater. 2009, 21, 2133-2148.
63. Corot, C.; Robert, P.; Idée, J.-M.; Port, M. Recent Advances in Iron Oxide Nanocrystal Technology for Medical Imaging. Adv. Drug Delivery Rev. 2006, 58, 1471-1504.
64. Moeller, M. J.; Tenten, V. Renal Albumin Filtration: Alternative Models to the Standard Physical Barriers. Nat. Rev. Nephrol. 2013, 9, 266-277.
65. Choi, H. S.; Liu, W.; Misra, P.; Tanaka, E.; Zimmer, J. P.; Itty Ipe, B.; Bawendi, M. G.; Frangioni, J. V. Renal Clearance of Quantum Dots. Nat. Biotechnol. 2007, 25, 1165-1170.
66. Dutz, S.; Andrä, W.; Hergt, R.; Müller, R.; Oestreich, C.; Schmidt, C.; Töpfer, J.; Zeisberger, M.; Bellemann, M. E. Influence of Dextran Coating on the Magnetic Behaviour of Iron Oxide Nanoparticles. J. Magn. Magn. Mater. 2007, 311, 51-54.
67. Bass, M.; DeCusatis, C. M.; Enoch, J. M.; Lakshminarayanan, V.; Li, G.; MacDonald, C.; Mahajan, V. N.; Van Stryland, E. Handbook of Optics. Optical Properties of Materials, Nonlinear Optics, Quantum Optics; McGraw-Hill: Columbus, OH, 2010; Vol. IV.